Thyroid dysfunction and risk of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a

Weijie Zhang1, Fushi Piao2, Wei Fu3

  • 1Department of Emergency, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.

Insights

Thyroid dysfunction, including subclinical and overt hypothyroidism, increases the risk of atrial fibrillation (AF) in patients with hypertrophic obstructive cardiomyopathy (HOCM). Thyroid optimization may be key for AF risk stratification in HOCM patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) is a significant arrhythmia in hypertrophic obstructive cardiomyopathy (HOCM).
  • The link between thyroid dysfunction and AF in HOCM patients is not well-established.
  • Thyroid hormones critically influence cardiac electrophysiology and atrial remodeling.

Purpose of the Study:

  • To investigate the association between thyroid-stimulating hormone (TSH) levels and incident AF in patients with HOCM.
  • To determine if thyroid dysfunction impacts AF risk in this specific patient population.
  • To explore the potential role of thyroid function in AF risk stratification for HOCM patients.

Main Methods:

  • Retrospective analysis of 755 HOCM patients across three tertiary centers (2019-2024).
  • Patients categorized by TSH levels: <0.55, 0.55-2.49 (reference), 2.50-9.99, and ≥10.00 mIU/L.
  • Multivariable logistic regression and Cox proportional hazards regression analyses were employed.

Main Results:

  • Elevated TSH levels (2.50-9.99 and ≥10.00 mIU/L) were independently associated with a higher risk of incident AF.
  • Odds Ratios (OR) for AF increased with TSH levels (e.g., OR 4.306 for TSH ≥10.00 mIU/L).
  • Restricted cubic spline analysis revealed a U-shaped association between TSH and AF risk.

Conclusions:

  • Both subclinical and overt hypothyroidism are linked to increased incident AF risk in HOCM patients.
  • Thyroid function status is a potential factor for AF risk stratification in HOCM.
  • Further prospective studies are needed to confirm if thyroid optimization can mitigate AF risk in HOCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952